Specialization : Pharmaceutics
E mail :rahul.maheshwari@nmims.edu,rahulgs.maheshwari@gmail.com
Phone : 9247023500-01
Experience : 11 years (Post PG); 05 years (Post PhD)
Dr. Rahul Maheshwari, Assistant Professor at SPTM Hyderabad, is an academic-researcher with >10 years of teaching, research and postdoctoral experience. He is a recipient of well-recognized National Postdoctoral Fellowship (N-PDF), awarded by SERB, DST, India. He completed his Postdoc research from National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A).
https://scholar.google.co.in/citations?user=WUQzwZkAAAAJ&hl=en&oi=ao
https://www.scopus.com/authid/detail.uri?authorId=54581307100
https://www.researchgate.net/profile/Rahul_Maheshwari11
Interest areas
1. Pharmaceutical Industrial Research (New product development)
The pharmaceutical Quality by Design (QbD) is a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management. Design of experiments (DOE), risk assessment, and process analytical technology (PAT) are tools that may be used in the QbD process when appropriate. Dr. Maheshwari is involved in some research projects based on QbD in collaboration with leading pharmaceutical companies.
2. Nanomedicines (Nanotechnology-based medicines)
Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of diseases. Research interest involves development of Lipid-based drug delivery system (Liposomes, ethosomes, transferosomes), nanoparticles (gold, silver, albumin, chitosan) for the delivery of ‘difficult to deliver’ therapeutic molecules.
3. Graphene-based delivery system
Graphene is the thinnest material known to be present on the earth. It is already proven material for the application in many sectors such as automobiles, IT, and energy-related. Its use in delivering the therapeutic molecules or as a biomaterial has opened the newer ways for pharmaceutical formulation scientists. Special interest in the development of graphene-based derivatives is because of its immense properties such as high loading efficiency, mechanical strength, and photothermal ability. Photothermal properties are of specific interest in the development of cancer therapeutics as the cells can be ablating when the temperature rises.
Research
Publications: 30 (International- 29, National- 1)
Book Chapters: 50
Patents- 01 (Filed)
Presentations- 12 (International- 06, National-06)
Conferences/Workshops/Seminars attended- 10
Government funded projects – 02
Awards
N-PDF Awarded by SERB, DST, Govt. of India
Awarded with the ‘Certificate of excellence in reviewing’ by the ‘Iranian Research Organization for Science & Technology (IROST), Ministry of Science, Research and Technology of Iran, Govt. of Iran for evaluating their Research Project they received under the prestigious Khwarizmi International Award (KIA).
"Research grant’’ awarded by MP Council of Science and Technology (MPCST), Bhopal, India
‘’International Travel Grant’’ awarded by MP Council of Science and Technology (MPCST), Bhopal, India
Professional Memberships
Member, Controlled Release Society-Indian Chapter for the term 2019-2023
Registered Pharmacist (MP, India)
Recent Publications
Nagaraja SreeHarsha, R Maheshwari, Bandar E Al-Dhubiab, M Tekade, M Sharma,N Venugopala, Rakesh Tekade, Abdullah M Alzahrani. Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy. International Journal of Nanomedicine, Dove Medical Press, UK. 14 7419-7429.2019.(IF 4.47)
PK Pandey, R Maheshwari, P Gandoliya, N Raval, Tekade RK; Nanogold-core Multifunctional Dendrimer for Pulsatile Chemo-, Photothermal- and Photodynamic- Therapy of Rheumatoid Arthritis; Journal of colloid and interface science (JCIS); 544, 61-77;2017.(IF 6.36)
D Kalyane, R Maheshwari, N Raval, RK Tekade;Employment of enhanced permeability and retention effect (EPR): Nanoparticle-Based Precision Tools for Targeting of Therapeutic and Diagnostic Agent in Cancer;Material Science and Engineering-C; 98, 1252-1276;2019.(IF 4.97)
M Shubhangi, A Patharkara, K Kuche, R Maheshwari, P Deb, K Kalia, R Tekade; Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer; International Journal of Pharmaceutics (IJP); 548,1, 540-558;2018. (IF 4.29)
K Kuche, R Maheshwari, V Tambe, H Jogi, N Raval, K Kalia, RK Tekade;Carbon nanotubes (CNTs) based advanced dermal therapeutics: Current trends and future potential.; Nanoscale/ Royal Society of Chemistry (RSC Journal);10, 8911-8937;2018. (IF 6.97)
H Jogi, R Maheshwari, K Kuche, N Raval, RK Tekade; Carbon nanotubes in the delivery of anticancer herbal drugs; Nanomedicine (London)/Future science group; 13, 1187-122;2018. (IF 4.71)
R Maheshwari, M Tekade, P Gondaliya, K Kalia, A D'Emanuele, RK Tekade;Recent advances in Exosome-based Nano vehicles as RNA interference (RNAi) therapeutics carriers; Nanomedicine (London)/Future science group; 12 (21):2653-2675;2017. (IF 4.71)
R Maheshwari, Umesh Atneriya, Rakesh K Tekade; Microsponge embedded tablet for sustained delivery of nifedipine;Pharmaceutical Nanotechnology/Bentham; 5(3):192-202;2017.
L Lalu, V Tambe, D Pradhan, K Nayak, S Bagchi, R Maheshwari, K Kalia, RK Tekade;Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions;Journal of Controlled Release/ Elsevier;268:19-39;2017. (IF 7.90)
N Soni, N Soni, H Pandey, R Maheshwari, P Kesharwani, RK Tekade; Augmented delivery of gemcitabine in lung cancer cells exploring mannose anchored solid lipid nanoparticles;Journal of Colloid and Interface Science/ Elsevier; 481: 107-116;2016. (IF 6.36)
